Signaling Pathways - sodium channel - TAK1 - Insulin and Insulin-like Receptors
清除全部
-
B7443 (5Z)-7-Oxozeaenol1 CitationTarget: TAK1Summary: TAK1促分裂原活化蛋白激酶激酶激酶（MAPKKK）抑制剂 -
B2278 Ibutilide Fumarate中文名: 富马酸伊布利特Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channelSummary: III类抗心律失常药物 -
B2249 Lamotrigine1 Citation中文名: 拉莫三嗪Target: 5-HT receptors|sodium channelSummary: 5-HT抑制剂，钠通道阻断剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A3374 Dronedarone中文名: 决奈达隆Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4和2D6抑制剂 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂